Reliability of Multiple-Repetition-Maximum Tests in Patients with Cardiovascular Disease or Risk Factors

NCT ID: NCT06796582

Last Updated: 2025-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-28

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Exercise training is a cornerstone in the prevention and rehabilitation of cardiovascular disease. While research has primarily focused on endurance training, resistance training becomes more and more important. The gold standard to prescribe resistance training intensity or monitor longitudinal changes is the 1-Repetition-Maximum (1-RM) test. However, particularly for unexperienced individuals, this test may not be recommendable due to the high load and an increased risk of injuries. Alternatively, there are several published formulas to estimate the 1-RM based on a multiple-repetition-maximum (or repetition-to-failure) test. However, these formulas have been primarily tested in healthy individuals. Moreover, the reliability of the 1-RM estimation based on two tests with different submaximal weight is unknown. Therefore, the present study evaluates the agreement of the 1-RM estimation (based on different formulas) between two Multiple-RM tests with different weight in 50 patients with cardiovascular disease (heart failure, coronary heart disease, atrial fibrillation) or cardiovascular risk factors (type 2 diabetes, arterial hypertension).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Coronary Heart Disease (CHD) Atrial Fibrillation (AF) Diabetes Mellitus Arterial Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 50 years
* At least one of the following cardiovascular diseases / risk factors:
* Heart failure
* Coronary heart disease
* Atrial fibrillation
* Arterial hypertension
* Type 2 diabetes mellitus
* Clinically stable for ≥ 4 weeks
* Medical clearance to perform resistance training / strength testing
* Signed written informed consent

Exclusion Criteria

* Pregnancy
* Acute infection
* Chronic joint inflammation
* Knee, hip, ankle, wrist, elbow or shoulder pain
* Known osteoporosis (T-value ≤ -2.5)
* Uncontrolled hypertension (≥160 mmHG systolic / ≥100 mmHG diastolic)
* Known cerebral or thoracic aneurysm
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Technical University of Munich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephan Mueller

Exercise Physiologist (Postdoctoral Researcher)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephan Mueller, Dr rer nat

Role: PRINCIPAL_INVESTIGATOR

Technical University of Munich, Department for Preventive Sports Medicine and Sports Cardiology

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stephan Mueller, Dr rer nat

Role: CONTACT

+49 (0)89 289 24494

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-27-S-CB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.